Caribou Biosciences, Inc. - Common Stock (NQ:CRBU)

1.190 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Caribou Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About... Yet ↗

July 07, 2023

Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...

Via Benzinga

Nasdaq Drops Over 100 Points; Genius Sports Shares Spike Higher ↗

July 06, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. The Dow traded down 1.09% to 33,913.56 while the NASDAQ fell 0.96% to 13,659.77. The...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 06, 2023

Via Benzinga

Crude Oil Moves Lower; ISM Services PMI Surges In June ↗

July 06, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. The Dow traded down 1.38% to 33,814.23 while the NASDAQ fell 1.37% to 13,602.19. The S&P 500,...

Via Benzinga

Caribou Biosciences: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Why Shares of Caribou Biosciences Are Skyrocketing Today ↗

July 06, 2023

The company's shares spiked after Pfizer bought $25 million of Caribou stock.

Via The Motley Fool

The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today ↗

July 06, 2023

Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE).

Via InvestorPlace

Pfizer (NYSE: PFE) Invests $25 Million in Caribou Biosciences (NASDAQ: CRBU)

July 06, 2023

On July 6, 2023, Caribou Biosciences, Inc., a significant player in the field of CRISPR genome-editing biopharmaceuticals, announced a $25

Via Spotlight Growth

Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗

July 06, 2023

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.

Via Benzinga

Pfizer Is Driving Caribou Biosciences Stock Higher Today: What's Going On? ↗

July 06, 2023

Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are racing higher on Thursday after the company announced a $25 million equity investment from

Via Benzinga

Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected ↗

July 06, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. Following the market opening Thursday, the Dow traded down 0.96% to 33,958.13 while the NASDAQ fell 1.06%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 06, 2023

Via Benzinga

Caribou Biosciences Announces $25 Million Equity Investment from Pfizer

July 06, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

June 21, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Caribou Biosciences to Participate in Upcoming Investor Conferences

May 31, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences, Inc. (NASDAQ:CRBU) Long Term Investor Alert: Investigation over Possible Wrongdoing ↗

May 22, 2023

San Diego, CA -- (SBWIRE) -- 05/22/2023 -- Certain directors of Caribou Biosciences, Inc. are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update

May 09, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board

May 08, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences to Participate in Upcoming Investor Conferences

May 01, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Presents New Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the 2023 AACR Annual Meeting

April 17, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate

April 10, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

CARIBOU DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. and Encourages Investors to Contact the Firm

April 07, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

CRBU FINAL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU

April 07, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NASDAQ:CRBU Investor Alert: Deadline on April 11, 2023 in Lawsuit Against Caribou Biosciences, Inc. Coming Up ↗

April 05, 2023

San Diego, CA -- (SBWIRE) -- 04/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on April 11, 2023 in the lawsuit filed for certain investors of Caribou Biosciences, Inc....

Via SBWire

Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma

April 04, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PLDT, Global Payments, Caribou, and Inspirato and Encourages Investors to Contact the Firm

April 02, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU

April 02, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Caribou Biosciences Initiates Dose Expansion Portion of CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients

March 29, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Announces Dosing of First Patient in the CaMMouflage Phase 1 Trial of CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma

March 29, 2023

From Caribou Biosciences, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm

March 27, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.